3-37002998-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000249.4(MLH1):​c.307-1403A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 152,172 control chromosomes in the GnomAD database, including 2,388 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.15 ( 2388 hom., cov: 32)

Consequence

MLH1
NM_000249.4 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel B:3

Conservation

PhyloP100: 0.0930

Publications

25 publications found
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Lynch syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 3-37002998-A-T is Benign according to our data. Variant chr3-37002998-A-T is described in ClinVar as Benign. ClinVar VariationId is 90152.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.302 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
NM_000249.4
MANE Select
c.307-1403A>T
intron
N/ANP_000240.1
MLH1
NM_001354628.2
c.307-1403A>T
intron
N/ANP_001341557.1
MLH1
NM_001354629.2
c.208-1403A>T
intron
N/ANP_001341558.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MLH1
ENST00000231790.8
TSL:1 MANE Select
c.307-1403A>T
intron
N/AENSP00000231790.3
MLH1
ENST00000456676.7
TSL:1
c.307-1403A>T
intron
N/AENSP00000416687.3
MLH1
ENST00000413740.2
TSL:1
c.307-1403A>T
intron
N/AENSP00000416476.2

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
23005
AN:
152054
Hom.:
2390
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0346
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.161
Gnomad ASJ
AF:
0.0983
Gnomad EAS
AF:
0.315
Gnomad SAS
AF:
0.302
Gnomad FIN
AF:
0.264
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.183
Gnomad OTH
AF:
0.132
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.151
AC:
23014
AN:
152172
Hom.:
2388
Cov.:
32
AF XY:
0.156
AC XY:
11592
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0346
AC:
1437
AN:
41542
American (AMR)
AF:
0.161
AC:
2454
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0983
AC:
341
AN:
3468
East Asian (EAS)
AF:
0.315
AC:
1628
AN:
5174
South Asian (SAS)
AF:
0.303
AC:
1461
AN:
4814
European-Finnish (FIN)
AF:
0.264
AC:
2789
AN:
10570
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.183
AC:
12436
AN:
68000
Other (OTH)
AF:
0.135
AC:
285
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
931
1863
2794
3726
4657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.162
Hom.:
343
Bravo
AF:
0.135
Asia WGS
AF:
0.277
AC:
961
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 15, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Lynch syndrome Benign:1
Sep 05, 2013
International Society for Gastrointestinal Hereditary Tumours (InSiGHT)
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:research

MAF >1%

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
12
DANN
Benign
0.87
PhyloP100
0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1540354; hg19: chr3-37044489; API